Teijin Limited

Tokyo Stock Exchange:3401.T

Sector

🧪 Materials

Industries

🔬 Chemicals & Advanced Materials

🖨 3D Printing

🧱 Composite Materials

🛢 Petrochemicals

⚗️ Plastics

Location

Japan

Market Cap

USD 1.54 B

Share Price

USD 8.00

Avg Daily Volume

708,245

Change (1 day)

0.86%

Change (1 year)

-6.85%

Change (YTD)

-6.21%

Teijin Limited Capital Expenditure for the year ending March 31, 2025: USD -382.61 M

Teijin Limited Capital Expenditure is USD -382.61 M for the year ending March 31, 2025, a -10.97% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).

Teijin Limited Capital Expenditure for the year ending March 31, 2024 was USD -429.73 M, a -1.12% change year over year.
Teijin Limited Capital Expenditure for the year ending March 31, 2023 was USD -434.58 M, a -73.61% change year over year.
Teijin Limited Capital Expenditure for the year ending March 31, 2022 was USD -1.65 B, a 199.35% change year over year.
Teijin Limited Capital Expenditure for the year ending March 31, 2021 was USD -550.16 M, a -15.87% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Capital Expenditure	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Depreciation And Amortization

Tokyo Stock Exchange: 3401.T

Teijin Limited

CEO	Mr. Akimoto Uchikawa
IPO Date	Jan. 4, 2000
Location	Japan
Headquarters	Kasumigaseki Common Gate West Tower
Employees	21,834
Sector	🧪 Materials
Industries Chemicals & Advanced Materials 🖨 3D Printing 🧱 Composite Materials 🛢 Petrochemicals ⚗️ Plastics

Description

Teijin Limited engages in the fibers, films and sheets, composites, healthcare, and IT businesses worldwide. It offers aramid fibers and polyethylene materials; carbon fibers, composite materials, and oxidized PAN fibers; polycarbonate sheets and films; high-density polyethylene porous films and materials; and microporous films. The company also provides PC resins, polyphenylene sulfide resins, molded parts, and additives; lightweight glass and carbon fiber reinforced composites for automotive applications; and polytrimethylene telephthalate products, artificial leather materials, polyester nanofibers, and recycled polyester fibers. In addition, it offers pharmaceuticals for bone and joint, respiratory, cardiovascular and metabolic, and other diseases; home oxygen therapy, non-invasive positive pressure ventilation, rehabilitation, and sleep disordered breathing related devices, as well as sonic accelerated fracture healing system and community-based integrated care system; and orthopedic implantable devices, and functional food ingredients. Further, the company provides Recopic, a radio-frequency identification technology for inventory management. Additionally, it develops and implements engineering solutions for various issues, such as environmental pollution, energy supply stability, and aging-related workforce population decline. Teijin Limited was incorporated in 1918 and is headquartered in Tokyo, Japan.